Published by: Kowsar

Viral and Psychiatric Disorders in Methadone Maintenance Therapy (MMT) Clients

Hamid Abousaeedi 1 , Omid Reza Hosseini 2 , * , Reza Bidaki 3 , Mahmood Sheikh Fathollahi 4 , Hamid Reza Goodarzi Nejad 5 , Golam Hossein Hassan Shahi 6 , Maryam Sahraei 7 , Shila Jalalpoor 8 and Mina Abousaiedi 9
Authors Information
1 Department of Infection Disease, Rafsanjan University of Medical Sciences, Rafsanjan, IR Iran
2 Department of Infectious and Tropical Diseases, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, IR Iran
3 Research Center of Addiction and Behavioral Sciences, Shahid Sadoughi University of Medical Sciences, Yazd, IR Iran
4 Department of Social Medicine and Environment Research Center, Rafsanjan University of Medical Sciences, Rafsanjan, IR Iran
5 Tehran Heart Center, Tehran University of Medical Sciences, Tehran, IR Iran
6 Department of Hematology, Rafsanjan University of Medical Sciences, Rafsanjan, IR Iran
7 School of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, IR Iran
8 Young Researchers Club, Shahreza Branch, Islamic Azad University, Shahreza, IR Iran
9 Department of Accounting, Kerman Branch, Islamic Azad University, Kerman, IR Iran
Article information
  • Thrita: December 2016, 5 (4); e36365
  • Published Online: March 27, 2016
  • Article Type: Research Article
  • Received: January 15, 2016
  • Revised: February 6, 2016
  • Accepted: February 29, 2016
  • DOI: 10.5812/thrita.36365

To Cite: Abousaeedi H, Reza Hosseini O, Bidaki R, Sheikh Fathollahi M, Goodarzi Nejad H R, et al. Viral and Psychiatric Disorders in Methadone Maintenance Therapy (MMT) Clients, Thrita. 2016 ;5(4):e36365. doi: 10.5812/thrita.36365.

© 2016, Thrita Journal. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Napier TC, Vocci FJ. Addiction to alcohol and drugs of abuse is a horrific tragedy for affected individuals and their families, and a financial, legal, and social burden for societies. Pharmacol Ther. 2005; 108(1): 1-2[DOI][PubMed]
  • 2. Rahimi-Movaghar A, Amin-Esmaeili M, Haghdoost AA, Sadeghirad B, Mohraz M. HIV prevalence amongst injecting drug users in Iran: a systematic review of studies conducted during the decade 1998-2007. Int J Drug Policy. 2012; 23(4): 271-8[DOI][PubMed]
  • 3. Perez Gonzalez K, Domingo-Salvany A, Hartnoll R. [Prevalence of human immunodeficiency virus and risk behaviours among opioid users seen in an emergency room]. Gac Sanit. 1999; 13(1): 7-15[PubMed]
  • 4. Des Jarlais DC, Friedman SR. HIV infection among intravenous drug users: epidemiology and risk reduction. AIDS. 1987; 1(2): 67-76[PubMed]
  • 5. Napoli C, Tafuri S, Pignataro N, Tedesco G, Maria AS, Quarto M. Risk factors for HBV/HIV/HCV in drug addicts: a survey of attendees of a department of pathological dependence. J Prev Med Hyg. 2010; 51(3): 101-4[PubMed]
  • 6. Caiaffa WT, Zocratto KF, Osimani ML, Martinez PL, Radulich G, Latorre L, et al. Hepatitis C virus among non-injecting cocaine users (NICUs) in South America: can injectors be a bridge? Addiction. 2011; 106(1): 143-51[DOI][PubMed]
  • 7. McGovern MP, McLellan AT. The status of addiction treatment research with co-occurring substance use and psychiatric disorders. J Subst Abuse Treat. 2008; 34(1): 1-2[DOI][PubMed]
  • 8. Zamani S, Kihara M, Gouya MM, Vazirian M, Nassirimanesh B, Ono-Kihara M, et al. High prevalence of HIV infection associated with incarceration among community-based injecting drug users in Tehran, Iran. J Acquir Immune Defic Syndr. 2006; 42(3): 342-6[DOI][PubMed]
  • 9. Shekarchizadeh H, Ekhtiari H, Khami MR, Virtanen JI. Patterns of pre-treatment drug abuse, drug treatment history and characteristics of addicts in methadone maintenance treatment in Iran. Harm Reduct J. 2012; 9: 18[DOI][PubMed]
  • 10. Moolchan ET, Umbricht A, Epstein D. Therapeutic drug monitoring in methadone maintenance: choosing a matrix. J Addict Dis. 2001; 20(2): 55-73[DOI][PubMed]
  • 11. Esteban J, de la Cruz Pellin M, Gimeno C, Barril J, Mora E, Gimenez J, et al. Detection of clinical interactions between methadone and anti-retroviral compounds using an enantioselective capillary electrophoresis for methadone analysis. Toxicol Lett. 2004; 151(1): 243-9[DOI][PubMed]
  • 12. Verster A, Buning E. Methadone guidelines. 2000;
  • 13. Golden J, O'Dwyer AM, Conroy RM. Depression and anxiety in patients with hepatitis C: prevalence, detection rates and risk factors. Gen Hosp Psychiatry. 2005; 27(6): 431-8[DOI][PubMed]
  • 14. Alavian SM, Tavallaei SA, Hoseini SM, Hedayati MR, Sepehrinia A. Prevalence of Depression in Chronic Hepatitis B and C Patients Treated with ‎Interferon. Trauma Mon. 2007; 12(2): 161-7
  • 15. Alavian SM. Hepatitis C infection in Iran; A review article. Arch Clin Infec Dis. 2009; 4(1): 47-59
  • 16. Haghdoost AA, Mostafavi E, Mirzazadeh A, Navadeh S, Feizzadeh A, Fahimfar N, et al. Modelling of HIV/AIDS in Iran up to 2014. J AIDS HIV Res. 2011; 3(12): 231-9[DOI]
  • 17. Parvaresh N, Masoudi A, Majidi-Tabrizi S, Mazhari S. The Correlation between Methadone Dosage and Comorbid Psychiatric Disorders in Patients on Methadone Maintenance Treatment. Addict Health. 2012; 4(1-2): 1-8[PubMed]
  • 18. Shirazi KK, Heydarnia E, Kamalianfard S, Heydarnia M, Fararooie M, Rahimi E. P01-104-Exploring the mental status of people with opium and heroin addiction. European Psychiatr. 2011; 26(1): 104

Cited By:


Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:


  • Hamid Abousaeedi: [PubMed] []
  • Omid Reza Hosseini: [PubMed] []
  • Reza Bidaki: [PubMed] []
  • Mahmood Sheikh Fathollahi: [PubMed] []
  • Hamid Reza Goodarzi Nejad: [PubMed] []
  • Golam Hossein Hassan Shahi: [PubMed] []
  • Maryam Sahraei: [PubMed] []
  • Shila Jalalpoor: [PubMed] []
  • Mina Abousaiedi: [PubMed] []